ENTITY
Sido Muncul

Sido Muncul (SIDO IJ)

130
Analysis
Health Care • Indonesia
Sido Muncul is an Indonesian company specializing in herbal medicine, pharmaceuticals, and food and beverage products. Its product categories include herbal medicine and supplements, such as the well-known Tolak Angin, along with food and beverages, and pharmaceutical items. The company is headquartered in Semarang, Central Java, Indonesia, and was established in 1940.
more
•22 Oct 2025 22:40•Broker

Healthcare: 3Q25 Preview: Hospitals Soft Vs. Consensus, Pharma Stable

Hospitals: 3Q25 patient vol. improved yoy from a low 3Q24 base; 9M25 in line with our (77%) but may miss cons (68%), HEAL & SILO drags.

Logo
218 Views
Share
bullish•Macroeconomics
•03 Oct 2025 20:11•Broker

Equity Strategy: Oct25 Picks: Sticking with Banks, Commodities, Telco

We maintain our positive stance on Banks as we expect better liquidity condition to be reflected in Sep25 CoF, combined with attractive yield.

Logo
502 Views
Share
•24 Jul 2025 20:03•Broker

Healthcare: 2Q25 Preview: Defensive Profile Intact Despite Growth Normalization

We also expect Pharma’s 1H25 earnings to be in-line with 54% run-rate, with KLBF’s intact cost-efficiency, potential quarterly rebound in SIDO.

Logo
284 Views
Share
•19 Jun 2025 19:51•Broker

Consumer Sector Waiting for a Clearer Sign: Between Caution and Catalyst

This continued downtrend suggests that households remain wary of economic uncertainties, particularly with muted wage growth and rising cost of...

Logo
256 Views
Share
bullish•Cross Asset Strategy
•18 Mar 2025 01:50

The Week That Was in ASEAN@Smartkarma - CPALL, Arwana Citramulia, and Sido Muncul

The past week saw insights on CP ALL PCL (CPALL TB), Arwana Citramulia (ARNA IJ), Sido Muncul (SIDO IJ), and AvePoint (AVPT US)

Logo
350 Views
Share
x